Research and Markets Global and US Hypertension Pipeline Report 2014-2017

Research and Markets Global and US Hypertension Pipeline Report 2014-2017

. DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/47rb45/hypertension) has announced the addition of the "Hypertension Pipeline Highlights - 2014 Update" report to their offering. The latest report Hypertension Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Hypertension market. It covers emerging therapies for Hypertension in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals. Clinical Trial Stages: The report provides Hypertension pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage. Drug Mechanism Classes: The report provides Hypertension pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds. Company: The report provides Hypertension pipeline molecules by the Originator Company. Short-term Launch Highlights: Find out which Hypertension pipeline products will be launched in the US and Ex-US till 2017. Summary: Hypertension phase 3 clinical trial pipeline molecules Hypertension phase 2 clinical trial pipeline molecules Hypertension phase 1 clinical trial pipeline molecules Hypertension preclinical research pipeline molecules Hypertension discovery stage pipeline molecules Hypertension pipeline molecules short-term launch highlights For more information visit .researchandmarkets.com/research/47rb45/hypertension